Jupiter Neurosciences, INC. (JUNS) — 10-Q Filings

All 10-Q filings from Jupiter Neurosciences, INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (4)

JUNS' Losses Mount Amid Soaring R&D, Cash Dwindles — Nov 14, 2025 Risk: high
Jupiter Neurosciences, Inc. (JUNS) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $6,069,866, a substantial
Jupiter Neurosciences Files Q2 2025 10-Q — Aug 19, 2025 Risk: medium
Jupiter Neurosciences, Inc. filed its 10-Q for the period ending June 30, 2025. The filing details financial performance and operational updates for the company
Jupiter Neurosciences Files Q1 2025 10-Q — May 15, 2025 Risk: low
Jupiter Neurosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Jupiter Orphan Therapeutics, Inc., i
Jupiter Neurosciences Files Q3 10-Q — Dec 23, 2024 Risk: low
Jupiter Neurosciences, Inc. filed its Q3 10-Q report on December 23, 2024, for the period ending September 30, 2024. The company, formerly Jupiter Orphan Therap

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX